If you have been living with PCOS — or suspect you might have it — the news from May 2026 may have caught your attention. The condition officially has a new name. PCOS has been renamed PMOS, and the medical world is taking note. But what does this actually mean for you? Is your diagnosis still valid? Does your treatment change? And why did this happen at all?
Here is a clear, honest breakdown of the PCOS vs PMOS question from a clinical perspective.
What Happened? PCOS Is Now Called PMOS
On 12 May 2026, a landmark global consensus published in The Lancet officially renamed polycystic ovary syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS). The renaming was the result of a 14-year international process led by Professor Helena Teede at Monash University, involving 56 leading academic, clinical, and patient organisations across six continents.
Over 22,000 people — patients and health professionals — contributed to the process through surveys, Delphi workshops, and expert panels. The PCOS name change 2026 is not a cosmetic update. It reflects a fundamental shift in how the medical community understands and communicates this condition.
Why Was the Name Changed?
The old name — polycystic ovary syndrome — was, quite simply, misleading. Here is why it had to go:
- Most women with PCOS do not have “cysts” The “cysts” visible on ultrasound are actually arrested follicles — small, immature egg follicles that did not complete development. They are not pathological cysts. This distinction matters, because for decades the word “cyst” caused unnecessary fear, confusion, and misdiagnosis.
- It is not just an ovarian condition PCOS affects the entire body — insulin regulation, cardiovascular health, metabolic function, skin, mental health, and weight. Naming it after one organ (the ovary) obscured all of this, leading doctors to focus too narrowly and patients to miss treatment for the systemic aspects of the condition.
- It delayed diagnoses Research showed that up to 70% of women with the condition remained undiagnosed. Much of that gap was attributed to the name itself — both patients and clinicians who did not see classic ovarian symptoms would overlook or dismiss the possibility.
- It created stigma The misunderstanding created around “cysts” and “ovary problems” led to shame, frustration, and women feeling their concerns were not taken seriously.
What Does PMOS Stand For?
Polyendocrine Metabolic Ovarian Syndrome — and every word is intentional:
- Poly-endocrine — acknowledges that multiple hormones are involved: androgens, insulin, neuroendocrine hormones. This is not a single-hormone disorder.
- Metabolic — recognises the strong metabolic component: insulin resistance, weight gain, elevated risk of type 2 diabetes, and cardiovascular implications.
- Ovarian — retains the role of the ovaries without reducing the entire condition to them.
- Syndrome — unchanged, correctly reflecting that this is a cluster of features, not a single disease.
This new name captures what people with this condition have lived with all along — a complex, whole-body hormonal disorder.
What Changed vs. What Stayed the Same
This is the most important section for anyone currently managing this condition.
What CHANGED
- The official name: PCOS → PMOS
- The clinical framing: from “ovarian disorder” to “systemic endocrine-metabolic condition”
- Research and funding priorities — broader focus now expected
- How the condition will be classified in international disease codes (ICD updates in progress)
- Future clinical guidelines will be updated by 2028 under the PMOS label
What Did NOT Change
- Your diagnosis is still valid. A PCOS diagnosis does not expire. PMOS is the same condition.
- Diagnostic criteria remain the same — irregular cycles, signs of elevated androgens (acne, excess hair, hair thinning), and ovarian appearance on ultrasound (Rotterdam criteria still apply)
- Your treatment plan stays the same — lifestyle modifications, medications like metformin or oral contraceptives, and fertility support continue as before
- PCOS symptoms you experience — irregular periods, acne, weight challenges, mood shifts, insulin resistance — are all still recognised under PMOS
During the 3-year transition period (through approximately 2028), you will see both terms used — often written as PMOS (formerly PCOS). Both refer to the same condition.
What This Means for Women in India
In India, PCOS (now PMOS) is one of the most common hormonal conditions in women of reproductive age, affecting roughly 1 in 8 women. Awareness has been growing, but the challenges of delayed diagnosis and incomplete treatment have been widely documented here too.
The renaming presents an opportunity: as awareness spreads, more women may recognise symptoms they had previously dismissed as just “hormonal issues” or “irregular periods.” The metabolic framing should also push for better screening of blood sugar, cholesterol, and cardiovascular markers — areas often skipped in standard PCOS management.
If you have been managing PCOS and your treatment plan feels incomplete — or if you have symptoms but no diagnosis — this is a good moment to revisit your care. A comprehensive PMOS consultation today would look at your hormones, metabolic health, skin, mental well-being, and reproductive goals together.
When Should You See a Doctor?
See a specialist if you experience:
- Irregular or missed periods
- Unexplained weight gain or difficulty losing weight
- Acne, excess facial/body hair, or scalp hair thinning
- Difficulty conceiving
- Fatigue, mood changes, or signs of insulin resistance
Early evaluation leads to better outcomes — and with the new understanding of PMOS, your doctor can now address the full picture of the condition, not just the reproductive aspects.
Dr. Shernaz Damkevala (Dastur) provides comprehensive PCOS/PMOS management at her clinic in Malad West, Mumbai — covering hormonal evaluation, metabolic assessment, and personalised treatment plans.
If fertility is a concern, explore fertility consultation services as a next step.
📍 P4, Ahura Nursing Home, Chunilal Giridharilal Marg, Malad West, Mumbai – 400064 📞 Book an Appointment
Also read: Gynaecology Services | Maternity Care
FAQs
Q1. Is PCOS the same as PMOS?
A: Yes. PMOS is simply the new official name for PCOS as of May 2026. The condition, symptoms, and treatments are identical.
Q2. When was PCOS renamed to PMOS?
A: On 12 May 2026, following a 14-year global consensus process published in The Lancet.
Q3. Does the PMOS name change affect my diagnosis?
A: No. If you were diagnosed with PCOS, your diagnosis remains fully valid. No re-testing is needed.
Q4. What does PMOS stand for?
A: Polyendocrine Metabolic Ovarian Syndrome — reflecting the hormonal (polyendocrine), metabolic, and ovarian dimensions of the condition.
Q5. Why was PCOS renamed?
A: The old name was medically inaccurate — most patients don’t have actual ovarian cysts. It also obscured the metabolic and systemic features of the condition, contributing to delayed diagnosis and stigma.
Q6. Does my PCOS treatment change because of the new name?
A: No. Your medications, lifestyle plan, and care protocol remain the same. Future guidelines (by 2028) may add metabolic and mental health components more formally.
Q7. Will doctors in India start using “PMOS” immediately?
A: Over the next 3 years, both PCOS and PMOS will be used. Full transition in medical records and guidelines is expected by 2028.
Q8. Does PMOS affect fertility?
A: Yes — as PCOS did. Hormonal imbalances under PMOS can affect ovulation and fertility. However, most women with PMOS can conceive with appropriate treatment and support.
Q9. How is PMOS diagnosed?
A: The same Rotterdam criteria used for PCOS apply: irregular periods, signs of elevated androgens, and ovarian appearance on ultrasound. At least two of the three criteria are needed.
Q10. Can I see a PMOS specialist in Malad West, Mumbai?
A: Yes. Dr. Shernaz Damkevala (Dastur) offers PMOS (formerly PCOS) consultations at Ahura Nursing Home, Malad West, Mumbai. Call 9136454451 to book.
CITATIONS & REFERENCES
- Teede HJ et al. — Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process — The Lancet, May 12, 2026 — https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00717-8/fulltext
- Endocrine Society — Polyendocrine Metabolic Ovarian Syndrome (PMOS) is the new name for PCOS — https://www.endocrine.org/news-and-advocacy/news-room/2026/pcos-name-change
- Johns Hopkins Medicine — PMOS (formerly PCOS) — https://www.hopkinsmedicine.org/health/conditions-and-diseases/polycystic-ovary-syndrome-pcos
- STAT News — PCOS’s new name is PMOS, a small letter change that required a big scientific process — https://www.statnews.com/2026/05/12/pcos-now-called-pmos-polyendocrine-metabolic-ovarian-syndrome/
- Contemporary OB/GYN — Global consensus renames PCOS to PMOS — https://www.contemporaryobgyn.net/view/global-consensus-renames-pcos-to-polyendocrine-metabolic-ovarian-syndrome-pmos-
